Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 9,198,900 | 9,198,900 | 0 | $322.70M | $294.46M | 40.77% | -$28.24M |
| Dyne Therapeutics, Inc.(DYN) | 5,462,846 | 4,644,386 | -818,460 | $106.85M | $84.20M | 11.66% | -$22.65M |
| Vor Biopharma Inc.(VOR) | 3,617,354 | 4,117,354 | +500,000 | $47.31M | $73.45M | 10.17% | +$26.14M |
| Engene Holdings Inc COM | 9,632,561 | 9,632,561 | 0 | $86.98M | $65.60M | 9.08% | -$21.38M |
| MapLight Therapeutics, Inc.(MPLT) | 3,226,400 | 3,226,400 | 0 | $56.67M | $65.59M | 9.08% | +$8.92M |
| Damora Therapeutics, Inc.(DMRA) | 0 | 2,441,000 | +2,441,000 | $0 | $63.22M | 8.75% | +$63.22M |
| Crescent Biopharma, Inc.(CBIO) | 1,677,852 | 1,677,852 | 0 | $19.90M | $30.82M | 4.27% | +$10.92M |
| Replimune Group, Inc.(REPL) | 2,808,368 | 2,808,368 | 0 | $27.30M | $21.48M | 2.97% | -$5.81M |
| Bicycle Therapeutics PlcADS | 3,468,430 | 3,468,430 | 0 | $24.56M | $16.09M | 2.23% | -$8.46M |
| Engene Holdings IncW EXP 10 31 2028 *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | $8.52M | $7.28M | 1.01% | -$1.24M |
| Rapt Therapeutics Inc | 1,833,333 | 0 | -1,833,333 | $62.09M | $0 | — | -$62.09M |